Recombinant ROR1 (Zilovertamab Biosimilar) 抗体
Quick Overview for Recombinant ROR1 (Zilovertamab Biosimilar) 抗体 (ABIN7581651)
抗原
抗体类型
适用
宿主
克隆类型
标记
应用范围
-
-
Expression System
- CHO Cells
-
原理
- Anti-ROR1 Reference Antibody (zilovertamab)
-
序列
- QVQLQESGPG LVKPSQTLSL TCTVSGYAFT AYNIHWVRQA PGQGLEWMGS FDPYDGGSSY NQKFKDRLTI SKDTSKNQVV LTMTNMDPVD TATYYCARGW YYFDYWGHGT LVTVSSASTK GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKKVEPKSCD KTHTCPPCPA PELLGGPSVF LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP REEQYNSTYR VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVYTL PPSRDELTKN QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLYSKLT VDKSRWQQGN VFSCSVMHEA LHNHYTQKSL SLSPGK,DIVMTQTPLS LPVTPGEPAS ISCRASKSIS KYLAWYQQKP GQAPRLLIYS GSTLQSGIPP RFSGSGYGTD FTLTINNIES EDAAYYFCQQ HDESPYTFGE GTKVEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
-
产品特性
- Anti-ROR1 Reference Antibody (zilovertamab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 146.14 kDa.
-
纯度
- >95 %
-
亚型
- IgG1
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
说明
-
Therapeutic Agents by Target and Mechanism: ROR1 antagonist
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
浓度
- 1 mg/mL
-
缓冲液
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
储存条件
- 4 °C,-80 °C
-
储存方法
- +4°C,-80°C
-
-
- ROR1 (Zilovertamab Biosimilar)
-
物质类
- Biosimilar
-
分子量
- 146.14 kDa
-
UniProt
- Q01973
抗原
-